These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38639607)

  • 1. Efficacy and Safety of Recombinant Human p53 Adenovirus Injection Combined with Radiotherapy or Concurrent Chemoradiotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-analysis.
    Zhang G; Su G
    Altern Ther Health Med; 2024 Sep; 30(9):78-84. PubMed ID: 38639607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Human Adenovirus-p53 Therapy for the Treatment of Cervical Cancer: A Meta-Analysis.
    Guo Y; Chen J; Zhang X; Fang M; Xu M; Zhang L; Rao E; Xin Y
    Front Oncol; 2021; 11():748681. PubMed ID: 34733786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer.
    Su X; Chen WJ; Xiao SW; Li XF; Xu G; Pan JJ; Zhang SW
    Hum Gene Ther; 2016 Dec; 27(12):1008-1014. PubMed ID: 27575731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-field radiotherapy for locally advanced cervical cancer.
    Thamronganantasakul K; Supakalin N; Kietpeerakool C; Pattanittum P; Lumbiganon P
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012301. PubMed ID: 30362204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma.
    Ma WS; Ma JG; Xing LN
    Anticancer Drugs; 2017 Feb; 28(2):230-236. PubMed ID: 27775992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human adenovirus-p53 therapy for the treatment of nasopharyngeal carcinoma: a meta-analysis.
    Yuan C; Xu XH; Chen Z
    Springerplus; 2016; 5(1):1885. PubMed ID: 27843742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of endostar combined with chemoradiotherapy versus chemoradiotherapy alone in locally advanced cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
    Maimaitiming N; Ma X; Wei Y; Cao L; Gao Y; Zhang L
    Medicine (Baltimore); 2022 Sep; 101(36):e30170. PubMed ID: 36086700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis.
    Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant adenovirus-p53 enhances the therapeutic effect of surgery and chemoradiotherapy combination in hypopharyngeal squamous cell carcinomas patients.
    Liu J; Lv D; Wang H; Zou J; Chen F; Yang H
    Medicine (Baltimore); 2018 Aug; 97(35):e12193. PubMed ID: 30170471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma.
    Pan JJ; Zhang SW; Chen CB; Xiao SW; Sun Y; Liu CQ; Su X; Li DM; Xu G; Xu B; Lu YY
    J Clin Oncol; 2009 Feb; 27(5):799-804. PubMed ID: 19103729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival of Patients With Cervical Cancer Treated With Definitive Radiotherapy or Concurrent Chemoradiotherapy According to Histological Subtype: A Systematic Review and Meta-Analysis.
    Yao G; Qiu J; Zhu F; Wang X
    Front Med (Lausanne); 2022; 9():843262. PubMed ID: 35299841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human adenovirus p53 combined with transcatheter arterial chemoembolization for liver cancer: A meta-analysis.
    Guo Y; Chen Y; Zhang Y; Xu M; Guo W; Zhang J; Ma G; Liu C; Yang J; Wu X
    PLoS One; 2023; 18(12):e0295323. PubMed ID: 38127912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
    Datta NR; Stutz E; Liu M; Rogers S; Klingbiel D; Siebenhüner A; Singh S; Bodis S
    Gynecol Oncol; 2017 May; 145(2):374-385. PubMed ID: 28188016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
    Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
    Liu C; Ran X; Wang Z; Zhang K
    Chin Clin Oncol; 2023 Aug; 12(4):38. PubMed ID: 37699603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant adenovirus p53 combined with radiotherapy improves efficacy and safety in the treatment of head and neck lymphoma.
    Xu YH; Liu SH; Hao FR; Zhang YH
    Cancer Biomark; 2018; 23(2):213-220. PubMed ID: 30198865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CALLA: Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study.
    Mayadev J; Nunes AT; Li M; Marcovitz M; Lanasa MC; Monk BJ
    Int J Gynecol Cancer; 2020 Jul; 30(7):1065-1070. PubMed ID: 32447296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant Chemotherapy Followed by Radical Surgery versus Radiotherapy (with or without Chemotherapy) in Patients with Stage IB2, IIA, or IIB Cervical Cancer: A Systematic Review and Meta-Analysis.
    Ye Q; Yang Y; Tang X; Li J; Li X; Zhang Y
    Dis Markers; 2020; 2020():7415056. PubMed ID: 32802215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.